Literature DB >> 21744351

Lysophosphatidic acid (LPA) and endothelial differentiation gene (Edg) receptors in human pancreatic cancer.

G M Lv1, P Li, W D Wang, Sh K Wang, J F Chen, Y L Gong.   

Abstract

Lysophosphatidic acid (LPA) is a naturally occurring phospholipid with diverse effects on various cells, ranging from immediate morphological change to long-lasting cellular function alteration such as induction of stimulation of cell proliferation, survival, drug resistance, and motility. LPA interacts with cells through specific cell surface receptors. LPA1/Edg-2, LPA2/Edg-4, and LPA3/Edg-7 are three most common LPA receptors. Herein we review the roles of LPA and its receptors in the carcinogenesis of human malignancies, with focus on pancreatic cancer.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21744351     DOI: 10.1002/jso.22016

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  4 in total

1.  The gep proto-oncogene Gα13 mediates lysophosphatidic acid-mediated migration of pancreatic cancer cells.

Authors:  Jacob A Gardner; Ji Hee Ha; Muralidharan Jayaraman; Danny N Dhanasekaran
Journal:  Pancreas       Date:  2013-07       Impact factor: 3.327

2.  Quantitative analysis of proteins related to chemoresistance to paclitaxel and carboplatin in human SiHa cervical cancer cells via iTRAQ.

Authors:  Yue He; Su Bin Han; Yu Ning Geng; Shu Li Yang; Yu Mei Wu
Journal:  J Gynecol Oncol       Date:  2019-11-07       Impact factor: 4.401

3.  Expression and function of lysophosphatidic acid receptors (LPARs) 1 and 3 in human hepatic cancer progenitor cells.

Authors:  Valentina Zuckerman; Eugene Sokolov; Jacob H Swet; William A Ahrens; Victor Showlater; David A Iannitti; Iain H Mckillop
Journal:  Oncotarget       Date:  2016-01-19

4.  Alpha conotoxin-BuIA globular isomer is a competitive antagonist for oleoyl-L-alpha-lysophosphatidic acid binding to LPAR6; A molecular dynamics study.

Authors:  Saima Younis; Sajid Rashid
Journal:  PLoS One       Date:  2017-12-06       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.